Skip to content

Carotid Duplex Ultrasound for Selecting Patients for Endovascular Thrombectomy in Acute Stroke Patients

Emergent Carotid Ultrasound in Hyperacute Cerebral Vessel Occlusion for Selecting Patients to be Treated With Endovascular Clot Retrieval Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02989376
Acronym
ECHO-SELECT
Enrollment
40
Registered
2016-12-12
Start date
2016-10-31
Completion date
2019-10-30
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

The aim of this study is to address the usefulness of carotid duplex ultrasound as vascular imaging for selecting acute stroke patients for endovascular thrombectomy.

Interventions

PROCEDUREAfter detection of occluded vessels by vascular imaging using carotid duplex ultrasound, digital subtraction angiography is immediately performed before acute endovascular treatment.

When the ratio of the end diastolic velocity in the common carotid arteries is greater than 1.4 or the diastolic flow in the internal carotid artery is not detected by vascular imaging using carotid duplex ultrasound, digital subtraction angiography is immediately performed before acute endovascular treatment. If vessel occlusion is not detected by carotid duplex ultrasound, additional vascular imaging including MR angiography or CT angiography is considered.

Sponsors

Ryo Itabashi
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Endovascular treatment can be initiated within 6 hours of symptom onset. * ASPECTS of \>=6 is diagnosed by two or more stroke physicians. * The end diastolic velocity in the common carotid arteries or internal carotid artery is evaluated by carotid duplex ultrasound * NIHSS score of \>=6. * Age\>=18 years. * Written informed consent is obtained.

Exclusion criteria

* Pre-stroke modified Rankin Scale (mRS) score \>=2. * Difficulties to evaluate ASPECTS on initial CT. * Difficulties to groin puncture. * History of severe allergic reaction to contrast medium. * End stage renal disease.

Design outcomes

Primary

MeasureTime frame
modified Rankin Scaleat 90 days after onset

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026